Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
Hosted on MSN21h
How Chinese biotech firm BGI grew to rival US giant Illumina & enter US-China tariff warChina has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...
Of the 11 new unicorns in January, five came from healthcare, including companies working on genetic research, drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback